Sanofi (WBO:SANO) Other Operating Expense : €5,042 Mil (TTM As of Dec. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Sanofi Other Operating Expense?

Sanofi's Other Operating Expense for the six months ended in Dec. 2024 was €2,588 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2024 was €5,042 Mil.

Sanofi's quarterly Other Operating Expense declined from Dec. 2023 (€2,535 Mil) to Jun. 2024 (€2,454 Mil) but then increased from Jun. 2024 (€2,454 Mil) to Dec. 2024 (€2,588 Mil).

Sanofi's annual Other Operating Expense increased from Dec. 2022 (€2,513 Mil) to Dec. 2023 (€4,375 Mil) and increased from Dec. 2023 (€4,375 Mil) to Dec. 2024 (€5,042 Mil).

Sanofi Other Operating Expense Historical Data

The historical data trend for Sanofi's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sanofi Other Operating Expense Chart

Sanofi Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Operating Expense

Get a 7-Day Free Trial

2,399.00

2,526.00

2,513.00

4,375.00

5,042.00

Sanofi Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Other Operating Expense	Get a 7-Day Free Trial															815.00	1,840.00	2,535.00	2,454.00	2,588.00

Sanofi Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €5,042 Mil.

Sanofi Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Sanofi's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Sanofi Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sanofi SA (WBO:SANO) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

SNYNF:USA SNY:USA SNY N:Mexico 1SAN:Italy 0A2V:UK SANp:UK 0O59:UK SAN:France SNW:Germany SNW:Bulgaria

Address

46, Avenue de la Great Army, Paris, FRA, 75017

Website

https://www.sanofi.com

Sanofi develops and markets drugs with a concentration in vaccines, immunology, oncology, cardiovascular disease, diabetes, and over-the-counter treatments. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing about 30% of total sales, but profits are shared with Regeneron. Just over 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.

Sanofi Headlines

No Headlines